KARA PHILLIPS: Open Payments
NPI 1649649716 · SALEM, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 12 payments from 7 companies in 2025. Trend: 2023 $435 · 2024 $334 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Alkermes, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $26 |
| Phadia US Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: FANAPT, CAPLYTA, ARISTADA, REXULTI, QUTENZA, ImmunoCAP, HETLIOZ, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
